IR@PKUHSC  > 北京大学第三临床医学院  > 肿瘤放疗科
学科主题临床医学
Permanent interstitial I-125 seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment
Yao, Lihong1; Wang, Junjie1; Jiang, Yuliang1; Li, Jinna1; Lin, Lei1; Ran, Weiqiang2; Liu, Chen3
关键词I-125 Seed Pediatric Soft Tissue Sarcoma Image Guided
刊名WORLD JOURNAL OF SURGICAL ONCOLOGY
2015-12-15
DOI10.1186/s12957-015-0747-7
13
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Surgery
研究领域[WOS]Oncology ; Surgery
关键词[WOS]RADIATION-THERAPY ; BRACHYTHERAPY SOURCES ; EXPERIENCE ; CARCINOMA ; RECOMMENDATIONS ; MANAGEMENT ; DOSIMETRY ; RESECTION ; CRITERIA ; HEAD
英文摘要

Background: The management of pediatric recurrent or metastatic soft tissue sarcoma after multimodal treatment remains challenging. We investigated the feasibility, efficacy, and morbidity of permanent interstitial I-125 seed implantation under image guidance as a salvage treatment for pediatric patients with recurrent or metastatic soft tissue sarcoma.

Methods: This was a retrospective study of 10 patients who underwent percutaneous ultrasound or computed tomography (CT) guided permanent I-125 seed implantation. Postoperative dosimetry was performed for all patients. Actuarial D90 was 121-187.1 Gy (median, 170.3 Gy). The number of I-125 seeds implanted was 6-158 (median, 34.5), with a median specific activity of 0.7 mCi per seed (range, 0.62-0.8 mCi); total activity was 4.2-113.76 mCi. Followup time was 6-107 months (median, 27.5 months); no patients were lost to follow-up.

Results: The overall response rate (complete response + partial response) was 8/10 (80 %), including two patients with complete response (CR) (20 %) and five patients with partial response (PR) (60 %). Local control rates after 1 and 2 years were 70.1 and 62.3 %, respectively, with a mean local control time of 70.6 months (95 % confidence interval (CI) 45.1-96.0). Survival rates after 1 and 2 years were 68.6 and 57.1 %, respectively, with a mean survival time of 65.3 months (95 % CI 34.1-96.5). Three patients died from distant metastasis; one died from local recurrence 12 months after seed implantation. Three patients suffered a grade I skin reaction and one developed ulceration. No severe adverse neurologic sequelae or blood vessel damage occurred.

Conclusions: Image guided permanent interstitial I-125 seed implantation as a salvage treatment appears to have a satisfactory outcome in children with recurrent or metastatic soft tissue sarcoma.

语种英语
WOS记录号WOS:000366713900001
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54867
专题北京大学第三临床医学院_肿瘤放疗科
北京大学第三临床医学院_肿瘤治疗中心
作者单位1.Peking Univ, Dept Radiat Oncol, Hosp 3, Beijing 100191, Peoples R China
2.Peking Univ, Dept Ultrasound, Hosp 3, Beijing 100191, Peoples R China
3.Peking Univ, Dept Radiol, Hosp 3, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Yao, Lihong,Wang, Junjie,Jiang, Yuliang,et al. Permanent interstitial I-125 seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment[J]. WORLD JOURNAL OF SURGICAL ONCOLOGY,2015,13.
APA Yao, Lihong.,Wang, Junjie.,Jiang, Yuliang.,Li, Jinna.,Lin, Lei.,...&Liu, Chen.(2015).Permanent interstitial I-125 seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment.WORLD JOURNAL OF SURGICAL ONCOLOGY,13.
MLA Yao, Lihong,et al."Permanent interstitial I-125 seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment".WORLD JOURNAL OF SURGICAL ONCOLOGY 13(2015).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yao, Lihong]的文章
[Wang, Junjie]的文章
[Jiang, Yuliang]的文章
百度学术
百度学术中相似的文章
[Yao, Lihong]的文章
[Wang, Junjie]的文章
[Jiang, Yuliang]的文章
必应学术
必应学术中相似的文章
[Yao, Lihong]的文章
[Wang, Junjie]的文章
[Jiang, Yuliang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。